UNITED THERAPEUTICS DEL Stock Quote

$123.01 arrow  Change: 1.38 %Chge: 1.13% Vol: 9,401
End Of Day Prices
High: 123.23 | Low: 120.62 | Open: 121.56 | Close: 123.01
52 Wk High: 168.71 | 52 Wk Low: 114.62 | Todays Pivot: 122.29
Sector: Healthcare and Pharmaceuticals add stock to watch list

UTHR Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Charles Riv Labs Intl 68.74 green arrow 30,341
Boston Scientific 17.415 red arrow 2,353,952
Abbott Labs 35.01 green arrow 463,558
Johnson & Johnson 98.53 red arrow 785,436
Covance 53.98 green arrow 679,600
Nuvasive 24.36 red arrow 23,983
Lilly Eli 66.95 red arrow 181,671
Pfizer 19.275 green arrow 3,007,296

Above is a small selection of related companies to United Therapeutics Del which compete alongside UTHR within the Healthcare and Pharmaceuticals sector. To see more related companies to UTHR, view our stock market today information page.

Online News For United Therapeutics Del

United Therapeutics Corporation (UTHR) CEO Sells $152,039.94 in Stock

United Therapeutics Corporation (NASDAQ:UTHR) CEO Martine A. Rothblatt sold 1,263 shares of United Therapeutics Corporation stock in a transaction dated Thursday, October 26th. The stock was sold at an average price of $120.38, for a total value of $ ...


United Therapeutics Corporation (NASDAQ:UTHR) Posts Earnings Results, Beats Estimates By $2.26 EPS

United Therapeutics Corporation (NASDAQ:UTHR) posted its quarterly earnings results on Wednesday, October 25th. The biotechnology company reported $6.27 earnings per share for the quarter, beating analysts’ consensus estimates of $4.01 by $2.26 ...


SteadyMed Ltd. (STDY) Reports Invalidation of United Therapeutics (UTHR) '393 ...

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. SteadyMed Ltd. (NASDAQ: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and ...


United Therapeutics (UTHR) Q3 Earnings Up Y/Y, Revenues Beat

United Therapeutics Corporation UTHR reported earnings of $6.27 per share in the third quarter of 2017, substantially higher than $3.50 per share in the year-ago quarter. The Zacks Consensus Estimate stood at $4.01 per share. However, adjusted earnings ...


BRIEF-STEADYMED RECEIVES FAVORABLE RULING FROM U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (UTHR)

Nov 14 (Reuters) - Steadymed Ltd: * ‍COURT OF APPEALS AFFIRMED A MARCH 31 RULING BY PATENT TRIAL & APPEAL BOARD INVALIDATING U.S. PATENT NO 8,497,393 OWNED BY UNITED THERAPEUTICS * ‍INVALIDITY DECISION WILL PRECLUDE UNITED THERAPEUTICS FROM ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a United Therapeutics Del quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for UTHR to choose from. Visit here to build your stock quote widget »